After a productive period of Chairmanship since 2022, Neuro-Bio is pleased to share that Dr Michal Zurawski will be transitioning to the role of Chairman of the Commercial Advisory Board. We would like to thank Mike for his contribution during his time as Chairman and look forward to his impact in his new role.
LATEST NEWS
- Neuro-Bio Featured in Webinar on Synthetic Binders in Diagnostics and Molecular Biology
- New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research
- Neuro-Bio’s first paper of 2026 has been published!
- Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
- CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures